patient selection for car-t therapy in nhl
Published 5 years ago • 75 plays • Length 9:17Download video MP4
Download video MP3
Similar videos
-
1:23
when should patients with nhl be referred for car t-cell therapy?
-
1:52
dr. locke on car t-cell therapy in nhl
-
4:05
car-t therapy for r/r aggressive b-cell nhl
-
5:22
selection criteria for car t therapy & infusion process
-
4:11
car t-cell therapies for relapsed/refractory nhl
-
29:00
dlbcl in 2023: top docs discuss the latest in diffuse large b-cell lymphoma | treatments & research
-
3:06
what is car-t cell therapy? #tms
-
1:31:59
non-hodgkin lymphoma stories: survivor talks chemo & car t-cell therapy | the patient story
-
0:23
copy of dr. locke on car t-cell therapy in nhl
-
6:10
car t-cell therapy in managing various lymphomas
-
4:19
car t treatment as new salvage therapy & transcend study
-
6:55
potential for car t-cell therapy in b-cell lymphomas
-
3:57
allogeneic car t-cell approaches for nhl
-
3:26
access to car t-cell therapy
-
4:18
what are the driving forces in patient selection for car t-cell therapy in aggressive lymphoma?
-
3:21
practical considerations for car-t therapy in lymphoma
-
3:11
will car t-cell therapy be used in patients with other than dlbcl types of nhl?
-
6:23
car-t therapy for dlbcl
-
15:03
treatment selection for peripheral t-cell lymphomas
-
5:38
rationale for further development of car t-cell therapy
-
7:11
car t-cell therapy response rates
-
4:20
investigating car t-cell therapy in lymphoma